EP3498292
USPA2 prótínbyggingar og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.2.2015EP published:
20.10.2021EP application number:
18211544.4
EP translation filed:
9.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
19.2.2035Expiry date:
19.2.2025
Title:
USPA2 PROTEIN CONSTRUCTS AND USES THEREOF
Timeline
Today
20.2.2015EP application
20.10.2021EP Publication
9.12.2021Translation submitted
15.1.2022Registration published
19.2.2025Expires
Owner
Name:
GlaxoSmithKline Biologicals SAAddress:
Rue de l'Institut, 89, 1330 Rixensart, BE
Inventor
Name:
BLAIS, NormandAddress:
1330 Rixensart, BE
Name:
CASTADO, CindyAddress:
1330 Rixensart, BE
Name:
CHOMEZ, PatrickAddress:
1330 Rixensart, BE
Name:
DEWERCHIN, MarianneAddress:
1330 Rixensart, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461943909 PDate:
24.2.2014Country:
US
Number:
201461946932 PDate:
30.3.2014Country:
US
Number:
201461946937 PDate:
3.3.2014Country:
US
Classification
Categories:
A61K 39/00, C07K 16/12, C07K 14/21
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 19.1.2022
Expires: 19.2.2023
Payer: Patice ehf.
Number: 9
Paid: 19.1.2023
Expires: 19.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.1.2024
Expires: 19.2.2025
Payer: Árnason Faktor ehf.